Market Access
Medicare drug pricing negotiations: What comes next?
Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the
Digital
The Life Sciences Generative AI Council and a sustainable te...
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo
Patients
Can self-navigating ADCs replace chemotherapy in the future?
ADCs are designed to deliver chemotherapy directly to tumours. However, more than 95% of the dose often ends up in healthy tissues, decreasing efficacy and increasing toxicity.
Digital
Structuring the unstructured: Deterministic AI and white box...
Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.
Digital
People need to know how to use AI now
With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharm
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
